about
A live imaging cell motility screen identifies prostaglandin E2 as a T cell stop signal antagonistHMBPP Analog Prodrugs Bypass Energy-Dependent Uptake To Promote Efficient BTN3A1-Mediated Malignant Cell Lysis by Vγ9Vδ2 T Lymphocyte EffectorsThe focal adhesion kinase inhibitor PF-562,271 impairs primary CD4+ T cell activation.Phosphinophosphonates and Their Tris-pivaloyloxymethyl Prodrugs Reveal a Negatively Cooperative Butyrophilin Activation Mechanism.Synthesis and biological evaluation of santacruzamate A analogues for anti-proliferative and immunomodulatory activity.Digeranyl bisphosphonate inhibits geranylgeranyl pyrophosphate synthase.Molecular mechanisms linking geranylgeranyl diphosphate synthase to cell survival and proliferation.Calpain inhibition impairs TNF-alpha-mediated neutrophil adhesion, arrest and oxidative burst.Geranylgeranyl diphosphate synthase inhibition induces apoptosis that is dependent upon GGPP depletion, ERK phosphorylation and caspase activation.Novel α-substituted tropolones promote potent and selective caspase-dependent leukemia cell apoptosis.Quantitative determination of farnesyl and geranylgeranyl diphosphate levels in mammalian tissue.Inhibition of geranylgeranyl diphosphate synthase induces apoptosis through multiple mechanisms and displays synergy with inhibition of other isoprenoid biosynthetic enzymes.Cyclopropene cycloadditions with annulated furans: total synthesis of (+)- and (-)-frondosin B and (+)-frondosin A.A power law function describes the time- and dose-dependency of Vγ9Vδ2 T cell activation by phosphoantigensToward Broad Spectrum Dihydrofolate Reductase Inhibitors Targeting Trimethoprim Resistant Enzymes Identified in Clinical Isolates of Methicillin Resistant Staphylococcus aureusRegulation of the Notch-ATM-abl axis by geranylgeranyl diphosphate synthase inhibitionPhosphonamidate Prodrugs of a Butyrophilin Ligand Display Plasma Stability and Potent Vγ9 Vδ2 T Cell StimulationProbing the Ligand-Binding Pocket of BTN3A1Stability and Efficiency of Mixed Aryl Phosphonate ProdrugsStructure-Activity Relationships of Butyrophilin 3 Ligands
P50
Q28247397-86F1B558-BF76-4D4B-BED5-206F2E38C6E0Q37072016-37E9004A-3720-4A30-AB9A-9E6106C0CCE2Q37146813-C09623FD-3E12-4847-BFE8-979AA38C41A0Q38715641-BA0FC3E4-2B15-4D9B-AB53-FF808176A817Q38822524-849B234B-71F2-450C-8F13-C9794B255F65Q40185807-EED91866-4215-4715-ACD5-019ADB1CDB0FQ41162635-FE313DDA-F7C4-4528-AFB4-3E79ACB78BC5Q42155804-A87C9E03-0216-461C-A8AF-758857CB09E0Q42292367-2524E894-C11F-4B1A-8C7D-72B73B618FA4Q42742732-2F6A8B62-4CF5-40B0-897A-D87238068E97Q42813567-46BA0630-BED8-4181-B6EF-820584BD5227Q46847315-FDD945D0-0847-4595-A4B2-55B92B01C315Q53064637-0819221E-7457-4E62-AA41-FC56474B5DCEQ58543705-4C322019-CD7F-427C-B5B8-0886F91A95A5Q90360549-0BBC920B-876C-4A65-84B5-A9D554D4ABACQ90390362-89AC0DCE-78EE-4EA2-964E-EA5A2FF2D344Q91356626-7DAE67D7-A2FE-4F78-A862-76FEDD432A30Q91579367-1106C685-AA79-427A-B1DC-10890FF96858Q92937452-5F589CA8-3FA9-42C1-ACF2-73049AAF6691Q95847211-4C3FA2FB-E297-407F-B807-DA1910EA3B68
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Andrew J. Wiemer
@ast
Andrew J. Wiemer
@en
Andrew J. Wiemer
@es
Andrew J. Wiemer
@nl
type
label
Andrew J. Wiemer
@ast
Andrew J. Wiemer
@en
Andrew J. Wiemer
@es
Andrew J. Wiemer
@nl
prefLabel
Andrew J. Wiemer
@ast
Andrew J. Wiemer
@en
Andrew J. Wiemer
@es
Andrew J. Wiemer
@nl
P1053
C-2257-2009
P106
P1153
6602955055
P21
P31
P3829
P496
0000-0002-3029-1780